APGE Earnings

Quarterly EPS
$-0.86
Q3 2024
$-1.17
Q4 2024
$-0.95
Q1 2025
$-1.13
Q2 2025
$-1.11
Q3 2025
$-1.03
Q4 2025
$-1.06
Q1 2026
$-1.14
Q2 2026
Latest RevenueN/A
Latest Net Income-85854000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$1.140-85854000-0.9%
Q1 2026-$1.060-74111000-11.6%
Q4 2025-$1.030-69387000+12.0%
Q3 2025-$1.110-65021000-29.1%
Q2 2025-$1.130-66096000-88.3%
Q1 2025-$0.950-55339000-48.4%
Q4 2024-$1.170-67218000-80.0%
Q3 2024-$0.860-49018000-68.6%
Q2 2024-$0.600-33816000
Q1 2024-$0.640-32094000
Q4 2023-$0.650-31735000
Q3 2023-$0.510-20840000
Apogee Therapeutics (APGE) — Earnings